Chicago, IL -- (SBWIRE) -- 03/01/2017 -- The global pharmaceutical contract manufacturing market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/pharmaceutical-contract-manufacturing-market

Buyers can expect to receive 10% customization on this report.

Key findings of the report:
- The pharmaceutical contract manufacturing market is expected to be driven by the strong growth in the healthcare spending around the world.

- The rising spending on healthcare infrastructure to improve the quality of healthcare is also expected to drive the pharmaceutical contract manufacturing market during the forecast period.

- The increasing prevalence of the diseases such as cancer and diabetes and the growth in the aging population around the world are influencing the demand for the therapeutic interventions. This is expected to drive the global pharmaceutical contract manufacturing market during the forecast period.

The pharmaceutical contract manufacturing market report segments the global market by the types, formulations, and the major geographic regions. The types segment is further divided into finished dosage forms, active pharmaceutical ingredients, and intermediates. The formulations segment is further divided into semi-solid formulations, solid formulations, liquid formulations, and other formulations. The major geographic regions in the pharmaceutical contract manufacturing market report include North America, Europe, Asia-Pacific, and Rest of the World.

Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=240

The pharmaceutical contract manufacturing market report provides analysis of the key players, including:
- Aenova Holding GmbH
- Baxter Healthcare Corporation
- Boehringer Ingelheim GmbH
- Catalent Pharma Solutions
- Hospira
- Jubilant Life Sciences
- Patheon, Inc.
- Recipharm AB

Browse Related Reports:
Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020
https://www.scalarmarketresearch.com/market-reports/prescription-pharmaceuticals-market
Molecular Diagnostics Market, by Products (Reagents, Consumables, Instruments, Systems), Technologies (PCR, INAAT, Microarrays, Immunochemical, Sequencing), Applications (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Microbiology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/molecular-diagnostics-market

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degreeperspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of the global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.
Find out more about our services at: www.scalarmarketresearch.com

Contact:
Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: mailto:sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research